Paid Clinical Trials in Washington

Washington has 1,831 paid clinical trials enrolling now across cities including Seattle, Spokane and Tacoma. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Washington include Fred Hutchinson Cancer Center, UW Medicine and Seattle Children's, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 19, 2026.

Filter results

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,831 clinical trials

↓ Download CSV

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

for Relapsing Multiple Sclerosis

22 locations incl. Palo Alto

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 18 - 55

Code: NCT04047628·Phase 3·Recruiting

Apply to this trial

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for Myelofibrosis

32 locations incl. Birmingham

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT04176198·Phase 1, Phase 2·Recruiting

Apply to this trial

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

for Tricuspid Regurgitation

73 locations incl. Phoenix

Sponsor: Edwards Lifesciences

Sex: All·Age: 18+

Code: NCT04097145·Recruiting

Apply to this trial

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

for Central Nervous System Tumor

1 location in Seattle

Sponsor: Seattle Children's Hospital

Sex: All·Age: 1 - 26

Code: NCT04185038·Phase 1·Recruiting

Apply to this trial

Trifecta-Kidney cfDNA-MMDx Study

for Kidney Transplant Rejection

11 locations incl. Tampa

Sponsor: University of Alberta

Sex: All·Age: All ages

Code: NCT04239703·Recruiting

Apply to this trial

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for Acute Leukemia

3 locations incl. Tampa

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 1 - 60

Code: NCT03970096·Phase 2·Recruiting

Apply to this trial

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

for BCR-JAK2 Fusion Protein Expression

Drug: Ruxolitinib

4 locations incl. Palo Alto

Sponsor: William Shomali

Sex: All·Age: 18+

Code: NCT03801434·Phase 2·Recruiting

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

203 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting

Apply to this trial

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

for Warm Antibody Autoimmune Hemolytic Anemia

Drug: Fostamatinib

8 locations incl. Los Angeles

Sponsor: Rigel Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT04138927·Phase 3·Enrolling By Invitation

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

for Psoriasis

7 locations incl. Fountain Valley

Sponsor: Bausch Health Americas, Inc.

Sex: All·Age: 6 - 17

Code: NCT03987763·Phase 4·Recruiting

Apply to this trial

Von Willebrand Factor in Pregnancy (VIP) Study

for Von Willebrand Diseases

11 locations incl. Aurora

Sponsor: University of Washington

Sex: Female·Age: 18+

Code: NCT04146376·Recruiting

Apply to this trial

Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

for Congenital Disorders of Glycosylation

12 locations incl. San Diego

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: All ages

Code: NCT04199000·Recruiting

Apply to this trial

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for Metastatic Castrate Resistant Prostate Cancer

18 locations incl. West Los Angeles

Sponsor: VA Office of Research and Development

Sex: Male·Age: 18+

Code: NCT04038502·Phase 2·Recruiting

Apply to this trial

A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

for Acute Myeloid Leukemia

21 locations incl. Fountain Valley

Sponsor: Taiho Oncology, Inc.

Sex: All·Age: 18+

Code: NCT04093570·Phase 2·Enrolling By Invitation

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

for Treatment Resistant Depression

101 locations incl. Birmingham

Sponsor: LivaNova

Sex: All·Age: 18+

Code: NCT03887715·Recruiting

Apply to this trial

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

for Metastatic Lung Non-Small Cell Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04151940·Recruiting

Apply to this trial

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for Advanced Solid Tumor

Drug: Tulmimetostat

17 locations incl. Atlanta

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT04104776·Phase 1, Phase 2·Recruiting

Apply to this trial

Stroke Thrombectomy and Aneurysm Registry

for Stroke

54 locations incl. Birmingham

Sponsor: Medical University of South Carolina

Sex: All·Age: 1 - 120

Code: NCT04994756·Recruiting

Apply to this trial

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

for Smoldering Plasma Cell Myeloma

Drug: Daratumumab

741 locations incl. Birmingham

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT03937635·Phase 3·Recruiting

Apply to this trial

Kidney Precision Medicine Project

for Acute Kidney Failure

13 locations incl. Tucson

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT04334707·Recruiting

Apply to this trial

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for Acute Biphenotypic Leukemia

10 locations incl. Los Angeles

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 6 Months - 26·Accepts healthy volunteers

Code: NCT03779854·Phase 2·Recruiting

Apply to this trial

Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study

for Renal Calculi

3 locations incl. San Diego

Sponsor: SonoMotion

Sex: All·Age: 18+

Code: NCT03811171·Recruiting

Apply to this trial

Cenobamate Open-Label Extension Study for YKP3089C025

for Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy

Drug: Cenobamate

16 locations incl. La Jolla

Sponsor: SK Life Science, Inc.

Sex: All·Age: 12+

Code: NCT03961568·Phase 3·Enrolling By Invitation

Pan Tumor Rollover Study

for Cancer

59 locations incl. Huntsville

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT03899155·Phase 2·Recruiting

Apply to this trial

Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)

for Renal Calculi

2 locations incl. Carmel

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT03873259·Recruiting

Apply to this trial

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

for Colonic Neoplasms

11 locations incl. Los Angeles

Sponsor: University of Michigan Rogel Cancer Center

Sex: All·Age: 18+

Code: NCT00843375·Recruiting

Apply to this trial

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

for Latent Tuberculosis

7 locations incl. Denver

Sponsor: Centers for Disease Control and Prevention

Sex: All·Age: All ages

Code: NCT03474029·Phase 2, Phase 3·Recruiting

Apply to this trial

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

for Glioblastoma

42 locations incl. Birmingham

Sponsor: Global Coalition for Adaptive Research

Sex: All·Age: 18+

Code: NCT03970447·Phase 2, Phase 3·Recruiting

Apply to this trial

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

for Stroke

45 locations incl. Tucson

Sponsor: W.L.Gore & Associates

Sex: All·Age: 18 - 70

Code: NCT03821129·Recruiting

Apply to this trial

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

for Acute Lymphoblastic Leukemia in Remission

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 75

Code: NCT03670966·Phase 1, Phase 2·Recruiting

Apply to this trial

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

for Clinical Stage I Esophageal Adenocarcinoma AJCC v8

95 locations incl. Phoenix

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT03801876·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

for Pediatric Epileptic Syndrome

22 locations incl. Phoenix

Sponsor: Eisai Inc.

Sex: All·Age: 1 Month - 18

Code: NCT04015141·Phase 2·Recruiting

Apply to this trial

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

for Lower Respiratory Tract Infection

49 locations incl. Duarte

Sponsor: Ansun Biopharma, Inc.

Sex: All·Age: All ages

Code: NCT03808922·Phase 3·Recruiting

Apply to this trial

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for Refractory Cancer

Drug: Nivolumab

13 locations incl. Stanford

Sponsor: Immatics US, Inc.

Sex: All·Age: 18+

Code: NCT03686124·Phase 1, Phase 2·Recruiting

Apply to this trial

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

for Mucositis

9 locations incl. La Jolla

Sponsor: Matrix Biomed, Inc.

Sex: All·Age: 18+

Code: NCT03480971·Phase 2·Recruiting

Apply to this trial

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for Bladder Adenocarcinoma

Drug: Cabozantinib

579 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03866382·Phase 2·Recruiting

Apply to this trial

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

275 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03739814·Phase 2·Recruiting

Apply to this trial

The GBA Multimodal Study in Parkinson's Disease

for Parkinson Disease

2 locations incl. Portland

Sponsor: Pacific Parkinson's Research Centre

Sex: All·Age: 18 - 80

Code: NCT04101968·Recruiting

Apply to this trial

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

for Advanced Ovarian Cancer

2 locations incl. Oklahoma City

Sponsor: Allarity Therapeutics

Sex: Female·Age: 18+

Code: NCT03878849·Phase 2·Recruiting

Apply to this trial

Clinical Pre-screening Protocol for Ovarian Cancer

for Ovarian Cancer

3 locations incl. Boston

Sponsor: Allarity Therapeutics

Sex: Female·Age: 18+

Code: NCT03877796·Recruiting

Apply to this trial